The progress in treating Multiple Sclerosis (MS) has been remarkable.
Before the era of disease-modifying therapies, individuals could expect 2 to 3 relapses annually. Now, with effective treatments, the average relapse rate has dropped significantly to one every 5 to 10 years.
